Brainsway BWAY
NASDAQ BWAY
$14.98 -0.19 (-1.25%)
As of: Aug 20, 2026 · 3:59 PM EDT

Brainsway (BWAY) Non-Current Debt (2018)

Brainsway's (BWAY) quarterly Non-Current Debt came in at $2.1 million in Q4 2018.

Brainsway (BWAY) Non-Current Debt (2018) Analysis & Trends

Brainsway (BWAY) has 1 years of Non-Current Debt data on file, last reported at $2.1 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 29.60 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 14.19 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 10.92 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.09 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 7.34 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 1.65 Bn
10 Brainsway 570.08 Mn 506.91 Mn 12.77 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 2.08 Mn